SlideShare a Scribd company logo
1 of 19
Running head: JUBLIA 1
JUBLIA 2
Jublia
Chamberlain College of Nursing
NR-293, Pharmacology
Linda Le
Professor Ward
February 14, 2019
Jublia
This brochure has been designed to inform the people about the
use of Efinaconazole for the treatment of onychomycosis.
Onychomycosis is known as a fungal infection of the nail. This
is targeted to educate the people on the treatment and use of
Jublia as a toenail treatment. The brochure explains a small
intro of necessary information regarding medicine like drug
class, mechanism of action, and treat guide. The side effects and
interactions are also explained. This is designed to provide
awareness to layman regarding toenail infections.
References
Elewski, B. E., Rich, P., Pollak, R., Pariser, D. M., Watanabe,
S., Senda, H., ... & Oli n, J. T. (2013).
Efinaconazole 10% solution in the treatment of toenail
onychomycosis: two phase III
multicenter, randomized, double-blind studies. Journal of the
American Academy of
Dermatology, 68(4), 600-608.
Tschen, E. H., Bucko, A. D., Oizumi, N., Kawabata, H., Olin, J.
T., & Pillai, R. (2013).
Efinaconazole solution in the treatment of toenail
onychomycosis: a phase 2, multicenter,
randomized, double-blind study. J Drugs Dermatol, 12(2), 186-
92.
RentSilverSpring.xlsx
DATASize (Square feet) Rent
($)52411106161175666119083014104501210550122578014808
15149010701495610168083518106601625590146967513957441
15082011409121220628143464515198401105800113080412509
50144980011687871224960139175011456901093840135385015
30965165010601740665123577515509601545827158365515755
35131062511957491200634118564114448601385740127559310
50880165089513406921560
Starbucks.xlsx
DATATearViscosityPressurePlate
Gap0.00350.00180.000.000.00350.00170.000.000.45319.00186.
001.800.85380.00174.001.800.35350.00180.000.000.30300.001
80.000.000.70400.00180.000.001.90350.00190.000.000.25350.0
0180.000.000.10319.00186.00-1.800.15380.00186.00-
1.803.90350.00180.003.000.00380.00174.00-
1.800.55350.00180.000.000.00350.00180.00-
3.000.05319.00174.00-
1.800.40319.00174.001.804.30380.00186.001.800.00350.00180.
000.00
VinhoVerde.xlsx
DATAFixed AcidityVolatile AcidityCitric AcidResidual
SugarChloridesFree Sulfur DioxideTotal Sulfur
DioxideDensitypHSulphatesAlcoholQuality11.50.30.620.067122
70.99813.110.9710.167.70.7150.012.10.06431430.993713.410.5
711.8610.40.5750.612.60.076112413.160.69959.20.630.212.70.
09729650.99883.280.589.657.90.350.463.60.07815370.99733.3
50.8612.888.90.7450.182.50.07715480.997393.20.479.767.60.5
10.242.40.0918380.9983.470.669.6610.80.50.462.50.0735271.0
0013.050.649.556.40.470.42.40.0718190.99633.560.7310.669.9
0.630.242.40.0776330.99743.090.579.456.90.68502.50.1052237
0.99663.460.5710.667.30.450.365.90.07412870.99783.330.8310
.556.80.810.0520.076140.995623.510.6610.867.50.510.021.70.0
8413310.995383.360.5410.5610.40.340.583.70.1746160.9973.1
90.711.367.10.460.142.80.07615370.996243.360.4910.759.10.5
0.31.90.0658170.997743.320.7110.567.30.690.322.20.06935104
0.996323.330.519.557.70.602.60.0557130.996393.380.5610.856
.70.460.241.70.07718340.99483.390.610.668.60.470.272.30.055
14280.995163.180.811.258.30.650.12.90.08917400.998033.290.
559.5560.310.473.60.06718420.995493.390.661168.60.490.281.
90.11201360.99722.931.959.967.90.540.342.50.0768170.99235
3.20.7213.1810.20.490.632.90.07210260.99683.160.7812.5780.
330.532.50.09118800.99763.370.89.667.60.390.312.30.0822371
0.99823.520.659.757.10.5902.10.0919140.994883.420.5511.578
.30.60.132.60.0856240.99843.310.599.268.80.460.452.60.06571
80.99473.320.791468.50.470.271.90.05818380.995183.160.851
1.1610.20.6450.361.80.0535140.99823.170.4210611.60.320.552
.80.08135671.00023.320.9210.876.30.550.151.80.07726350.993
143.320.8211.667.50.380.482.60.07322840.99723.320.79.649.1
0.7650.041.60.0784140.9983.290.549.748.41.0350.1560.073115
40.9993.370.499.956.20.560.091.70.05324320.994023.540.611.
357.30.740.081.70.09410450.995763.240.59.857.80.390.4220.0
869210.995263.390.6611.6610.40.440.421.50.14534480.998323
.380.869.9311.60.470.441.60.14736510.998363.380.869.948.30.
650.12.90.08917400.998033.290.559.556.30.550.151.80.077263
50.993143.320.8211.666.71.040.082.30.06719320.996483.520.5
71147.20.330.331.70.0613130.9963.231.11086.80.81501.20.267
16290.994713.320.519.835.50.490.031.80.04428870.99083.50.8
21487.40.590.084.40.0866290.99743.380.594
13.313.3 A small business analyst seeks to determine which
variablesshould be used to predict small-business mean annual
revenuefor U.S. metropolitan areas. The analyst decides to
considerthe independent variables age, the mean age (in
months) of smallbusinesses in the metropolitan area; and
BizAnalyzer, the meanBizAnalyzer score of small businesses in
the metropolitan area.(The BizAnalyzer score measures on a
scale of 1 to100 the levelof risk that the small businesses in the
metropolitan area present topotential lenders.) The dependent
variable, revenue, is mean annualrevenue. Using data collected
from a sample of 25 metropolitanareas, the regression results
are:a. State the multiple regression equation.b. Interpret the
meaning of the slopes, b1 and b2, in this problem.c. What
conclusions can you reach concerning mean annualrevenue?
13.513.5 The production of wine is a multibillion-dollar
worldwideindustry. In an attempt to develop a model of wine
qualityas judged by wine experts, data was collected from red
winevariants of Portuguese “Vinho Verde” wine. A sample of
50wines is stored in VinhoVerde . (Data extracted from P.
Cortez,A. Cerdeira, F. Almeida, T. Matos, and J. Reis,
“Modeling WineDecision Support Systems, 47, 2009, pp. 547–
553 and bit.ly/9xKlEa.) Develop a multiple linear regression
model to predictwine quality, measured on a scale from 0 (very
bad) to 10 (excellent)based on alcohol content (%) and the
amount of chlorides.a. State the multiple regression equation.b.
Interpret the meaning of the slopes, b1 and b2, in this
problem.c. E xplain why the regression coefficient, b0, has no
practicalmeaning in the context of this problem.d. Predict the
mean wine quality rating for wines that have 10%alcohol and
chlorides of 0.08.e. Construct a 95% confidence interval
estimate for the meanwine quality rating for wines that have
10% alcohol and chloridesof 0.08.f. Construct a 95% prediction
interval for the wine quality rating foran individual wine that
has 10% alcohol and chlorides of 0.08.g. What conclusions can
you reach concerning this regressionmodel?
Jublia
EFINACONAZOLE (EF-IN-A-KON-A-ZOLE)
DRUG CLASS
This drug belongs to the class `Azole antifungal`
ACTION
Inhibits lanosterol 14a-demethylase which involved in synthesis
of a constituent of fungal cell membranes.
DOSE INFORMATION
Once daily for 48 weeks.
DRUG INTERACTIONS
It may interact with other medicines you take. It is better to
inform the doctor about outer medicines you are currently
taking.
adverse effects
Itchiness, blister, and swelling. Allergic reaction in rare cases.
ASSESSMENT
Inspect the affected area thoroughly as it is slow process. A
feeling of itchiness may indicate a need to continue medicine.
Patient education
The treatment of onychomycosis may take up to 48 weeks. Do
not discontinue its usage even if symptoms diminish. Complete
the full course as directed by the doctor. Avoid pedicure, nail
enamel or any cosmetics on the affected area during therapy.
Inform the doctor if the patient is pregnant or a lactating
mother. Wait 10 minutes after washing the area to apply the
medicine.
NURSING MANAGEMENT
Apply Jublia on the affected toenail. Make sure the toenail is
completely dry and clean prior to the application. Use a flow
through brush in the applicator for the application. Make sure
the effects area is completely covered with the solution.
.MsftOfcThm_Accent3_Fill {
fill:#1F1F50;
}
Medication Teaching Plan Assignment GuidelinesPurpose
The purpose of this assignment is for the student to
synthesize pharmacological knowledge (i.e., core drug
knowledge, core patient variables, and nursing
implications) of pharmacotherapeutic agents into a useful
teaching and learning tool for nurses and patients.
Course Outcomes This assignment enables the student to meet
the following course outcomes.
· CO1 Apply the concepts of pharmacotherapeutics,
pharmacokinetics, pharmacodynamics, and pharmacogenomics
to the use of specific medication classifications in specific
health conditions and in consideration of medication
side/adverse effects, nursing implications, and medication
teaching. (POs 1, 2, and 3)
· CO2 Apply principles of health promotion, as well as illness
and injury prevention, to promote safety and effectiveness of
commonly used pharmacologic therapy across the lifespan,
taking into consideration sociocultural, genetic/genomic,
developmental, and gender implications. (POs 3 and 8)
· CO3 Utilize the nursing process in understanding the effects
of drug therapy on health outcomes across the lifespan within
the framework of a diverse population of individuals, families,
and communities. (PO 4)
Due Date
Refer to Course Calendar for details. The Late Assignment
Policy applies to this assignment.
Total Points Possible
100 PointsRequirements
1. Choose a pharmacological agent that has been on the market
less than 5 years.
2. Research the literature and obtain two to three resources for
current, evidence-based information related to the
pharmacological agent. You must submit your resources with
the assignment. Identify the following key/relevant drug
information that will be used to develop a medication teaching
brochure:
· Drug Class
· Mechanism of Action
· Drug Administration and Dosage
· Drug/food Interactions
· Lab effects/Interference
3. Design a brochure to be used as a patient teaching tool
containing the identified relevant/key
information outlined above and the following important
information:
· Nursing Management
· Patient Education Considerations
· Patient Assessment
· Potential Side Effects/Adverse Effects/Toxicities
· Special considerations
Preparing the Assignment
1. After selecting your pharmacotherapeutic agent, use the
Chamberlain online library or other database to research the
key/relevant drug information.
2. Create your teaching brochure using MS Word or
PowerPoint. Microsoft Word has built-in and online templates
for brochures. You may choose one of these for your format.
The brochure should be printed on one page, two-sided.
3. Include appropriate images, graphics, bulleted items, and
subtitles in your brochure. Choose images that illustrate your
points and do not serve as mere decorations.
4. Use no higher than seventh-grade reading level, except for
required medical terminology. Microsoft Word will calculate a
Flesch Kincaid Grade Level for you. Go to Review > Spelling
and Grammar. When the check is complete, Word will give you
the statistics. You may need to save your file with a new name
and temporarily delete required medical terms and then run the
Flesch Kincaid statistics again to get to the seventh-grade
reading level.
5. Complete a separate document that contains the following
information:
· Your name, date and class
· A short paragraph describing the intended audience and use
for your teaching brochure. For example, is this for teaching a
pediatric patient who is newly diagnosed with asthma about the
new drug? Is it designed to teach an older adult about a new
cholesterol drug?
· A reference page in APA format
The brochure is not a paper that follows APA format
so please use your creativity when developing the
brochure. Consider your audience when choosing
font, style and graphics.
6. Submit the brochure and the one-page document to the
assignment by the due date. Directions and
Assignment Criteria
Category
Points
%
Description
Brochure: Key/Relevant Drug Information
30
30%
Brochure contains following key/relevant drug information
· Drug Class
· Mechanism of Action
· Drug Administration and Dosage
· Drug Interactions
· Lab effects/interference
· Special Considerations
· Potential Side Effects/Adverse Effects/Toxicities
Brochure: Patient Education Considerations
35
35%
Brochure contains the following patient education information
· Nursing Management
· Patient Education Considerations
· Patient Assessment
· Potential Side Effects/Adverse Effects/Toxicities
· Special considerations
Brochure: Visual Effects/Creativity
10
10%
Brochure meets all of the following
· Developed per the required standard
· Appropriate for the intended audience
· Flesch Kincaid reading level is not higher than seventh grade
· Graphics do not distract from the purpose of the brochure
· Visually appealing
One Page Paper
15
15%
One page paper is clearly written and contains the following
information:
· Name
· Date
· Class
· A short paragraph describing the intended audience and use
for the teaching brochure.
· A reference page
APA format
5
5%
Reference page is present and follows APA format. At least two
sources are used and submitted with work
Writing Mechanics
5
5%
Writing follows rules of grammar, spelling, word usage,
punctuation, and other aspects of formal written work as found
in the 6th edition of the APA manual
Total
100
100%
NR293Pharmacology for Nursing Practice
NR293 Medication Teaching Plan Assignment Guidelines.docx
Revised 03/13/2018
WS/SCM
1
Grading Rubric
Category
Brochure: Key/Relevant Drug Information
30 Points
25 Points
20 Points
15 points
0 Points
Presentation of information on brochure is accurate and
includes all of the following elements:
· Drug Class
· Mechanism of Action
· Drug Administration and Dosage
· Drug Interactions
· Lab effects/interference
· Special Considerations
· Potential Side Effects/Adverse Effects/Toxicities
Presentation of informationon brochure is accurate and includes
six(6) of the following elements:
· Drug Class
· Mechanism of Action
· Drug Administration and Dosage
· Drug Interactions
· Lab effects/interference
· Special Considerations
· Potential Side Effects/Adverse Effects/Toxicities
Presentation of information on brochureis accurate andincludes
five (5) of the following elements:
· Drug Class
· Mechanism of Action
· Drug Administration and Dosage
· Drug Interactions
· Lab effects/interference
· Special Considerations
· Potential Side Effects/Adverse Effects/Toxicities
Presentation of informationon brochure is accurate and includes
four (4) of the following elements:
· Drug Class
· Mechanism of Action
· Drug Administration and Dosage
· Drug Interactions
· Lab effects/interference
· Special Considerations
· Potential Side Effects/Adverse Effects/Toxicities
Presentation of informationon brochure includes less than four
(4) of the following elements:
· Drug Class
· Mechanism of Action
· Drug Administration and Dosage
· Drug Interactions
· Lab effects/interference
· Special Considerations
· Potential Side Effects/Adverse Effects/Toxicities
Brochure: Patient Education Considerations
35 points
25 Points
15 Points
10 Points
0 Points
Presentation of informationon brochure is accurate and includes
all of the following elements:
· Nursing Management
· Patient Education Considerations
· Patient Assessment
· Potential Side Effects/Adverse Effects/Toxicities
· Special considerations
Presentation of informationon brochure is accurate and includes
four(4) of the following elements:
· Nursing Management
· Patient Education Considerations
· Patient Assessment
· Potential Side Effects/Adverse Effects/Toxicities
· Special considerations
Presentation of informationon brochure is accurate and includes
three (3) of the following elements:
· Nursing Management
· Patient Education Considerations
· Patient Assessment
· Potential Side Effects/Adverse Effects/Toxicities
· Special considerations
Presentation of informationon brochure is accurate and includes
two (2) of the following elements:
· Nursing Management
· Patient Education Considerations
· Patient Assessment
· Potential Side Effects/Adverse Effects/Toxicities
· Special considerations
Presentation of informationon brochure includes less than two
(2) of the following elements:
· Nursing Management
· Patient Education Considerations
· Patient Assessment
· Potential Side Effects/Adverse Effects/Toxicities
· Special Considerations
·
Brochure: Visual Effects/Creativity
10 Points
8 Points
6 Points
4 Points
0 Points
Presentation of informationon brochureincludes all of the
following elements:
· Developed per the required standard
· Appropriate for the intended audience
· Flesch Kincaid reading level is not higher than seventh grade
· Graphics do not distract from the purpose of the brochure
· Visually appealing
Presentation of informationon brochure includes four (4) of the
following elements:
· Developed per the required standard
· Appropriate for the intended audience
· Flesch Kincaid reading level is not higher than seventh grade
· Graphics do not distract from the purpose of the brochure
· Visually appealing
Presentation of informationon brochure includes three (3) of the
following elements:
· Developed per the required standard
· Appropriate for the intended audience
· Flesch Kincaid reading level is not higher than seventh grade
· Graphics do not distract from the purpose of the brochure
· Visually appealing
Presentation of informationon brochure includes two (2) of the
following elements:
· Developed per the required standard
· Appropriate for the intended audience
· Flesch Kincaid reading level is not higher than seventh grade
· Graphics do not distract from the purpose of the brochure
· Visually appealing
Presentation of information on brochureincludes less than
two(2) of the following elements:
· Developed per the required standard
· Appropriate for the intended audience
· Flesch Kincaid reading level is not higher than seventh grade
· Graphics do not distract from the purpose of the brochure
· Visually appealing
One page paper
15 Points
12 Points
9 Points
6 Points
0 Points
Presentation of information in the paperis clearly written
andincludes all of the following elements:
· Name
· Date
· Class
· A short paragraph describing the intended audience and use
for the teaching brochure.
· A reference page
Presentation of informationin the paper is clearly written and
includes four (4) of the following elements:
· Name
· Date
· Class
· A short paragraph describing the intended audience and use
for the teaching brochure.
· A reference page
Presentation of informationin the paper is clearly written and
includes three (3) of the following elements:
· Name
· Date
· Class
· A short paragraph describing the intended audience and use
for the teaching brochure.
· A reference page
Presentation of informationin the paper is clearly written
andincludes two (2) of the following elements:
· Name
· Date
· Class
· A short paragraph describing the intended audience and use
for the teaching brochure.
· A reference page
Presentation of informationin the paperincludes less than two
(2) of the following elements:
· Name
· Date
· Class
· A short paragraph describing the intended audience and use
for the teaching brochure.
· A reference page
APA Format
5 Points
4 Points
0 Point
APA guidelines, as per the 6th edition of the manual, are
demonstrated for all the following:
· Reference page is present and follows APA format
· At least two sources are used and submitted with work
APA guidelines, as per the 6th edition of the manual, are
demonstrated for one (1) of the following:
· Reference page is present and follows APA format
· At least two sources are used and submitted with work
APA guidelines, as per the 6th edition of the manual, are
demonstrated for none of the following:
· Reference page is present and follows APA format
· At least two sources are used and submitted with work
Writing Mechanics
5 Points
4 Points
3 Points
1 Point
0 Point
0–2 errors or exceptions to the rules of grammar, spelling, word
usage, punctuation, and other aspects of formal written work as
found in the 6th edition of the APA manual
3–4 errors or exceptions to the rules of grammar, spelling, word
usage, punctuation, and other aspects of formal written work as
found in the 6th edition of the APA manual
5–6 errors or exceptions to the rules of grammar, spelling, word
usage, punctuation, and other aspects of formal written work as
found in the 6th edition of the APA manual
7–8 errors or exceptions to the rules of grammar, spelling, word
usage, punctuation, and other aspects of formal written work as
found in the 6th edition of the APA manual
9 or greater errors or exceptions to the rules of grammar,
spelling, word usage, punctuation, and other aspects of formal
written work as found in the 6th edition of the APA manual
Total Points Possible = 100 points Student’s
Score ______/100 Points
Comments:
NR293 Medication Teaching Plan Assignment Guidelines.docx
Revised 03/13/2018 WS/SCM
7

More Related Content

Similar to Running head JUBLIA1JUBLIA2JubliaChambe.docx

Rational drug rx and writing dentistry for print
Rational drug rx and writing dentistry for printRational drug rx and writing dentistry for print
Rational drug rx and writing dentistry for printAhmed Al-Arwali
 
Multiple health problems in elderly peoplepage 950Ex.docx
Multiple health problems in elderly peoplepage 950Ex.docxMultiple health problems in elderly peoplepage 950Ex.docx
Multiple health problems in elderly peoplepage 950Ex.docxgilpinleeanna
 
Evaluation of cutaneous adverse drug reactions due to antimicrobial agents: A...
Evaluation of cutaneous adverse drug reactions due to antimicrobial agents: A...Evaluation of cutaneous adverse drug reactions due to antimicrobial agents: A...
Evaluation of cutaneous adverse drug reactions due to antimicrobial agents: A...iosrjce
 
New antifungals and TB research
New antifungals and TB researchNew antifungals and TB research
New antifungals and TB researchGraham Atherton
 
Awareness and attitudes of healthcare professionals in baguio benguet towards...
Awareness and attitudes of healthcare professionals in baguio benguet towards...Awareness and attitudes of healthcare professionals in baguio benguet towards...
Awareness and attitudes of healthcare professionals in baguio benguet towards...Alexander Decker
 
Antimicrobial-stewardship.ppt
Antimicrobial-stewardship.pptAntimicrobial-stewardship.ppt
Antimicrobial-stewardship.pptNehaPandey199
 
Local_Drug_Delivery_in_Periodontics.pdf
Local_Drug_Delivery_in_Periodontics.pdfLocal_Drug_Delivery_in_Periodontics.pdf
Local_Drug_Delivery_in_Periodontics.pdfvineetarun1
 
THESIS ENGLISH PRESENTATION
THESIS ENGLISH PRESENTATIONTHESIS ENGLISH PRESENTATION
THESIS ENGLISH PRESENTATIONOlivier ANGIBAUD
 
BIOTECHNOLOGY AND ITS APPLICATION TO VETERINARY SCIENCE
BIOTECHNOLOGY AND ITS APPLICATION TO VETERINARY SCIENCEBIOTECHNOLOGY AND ITS APPLICATION TO VETERINARY SCIENCE
BIOTECHNOLOGY AND ITS APPLICATION TO VETERINARY SCIENCEShedrick Charles Nyangiti
 
Detection of Drug Interactions via Android Smartphone: Design and Implementat...
Detection of Drug Interactions via Android Smartphone: Design and Implementat...Detection of Drug Interactions via Android Smartphone: Design and Implementat...
Detection of Drug Interactions via Android Smartphone: Design and Implementat...IJECEIAES
 
Haapalinna the new modalities ecosystem project what is there for me
Haapalinna the new modalities ecosystem project what is there for meHaapalinna the new modalities ecosystem project what is there for me
Haapalinna the new modalities ecosystem project what is there for meAntti Haapalinna
 
Short courses in food safety risk assessment
Short courses in food safety risk assessmentShort courses in food safety risk assessment
Short courses in food safety risk assessmentEFSA EU
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
PharmacovigilanceHebaHammam
 
Ofloxacin induced multiple fixed drug eruptions – A case report
Ofloxacin induced multiple fixed drug eruptions – A case reportOfloxacin induced multiple fixed drug eruptions – A case report
Ofloxacin induced multiple fixed drug eruptions – A case reportpharmaindexing
 
Research article Pharmacists cognitive service and pharmaceutical care today ...
Research article Pharmacists cognitive service and pharmaceutical care today ...Research article Pharmacists cognitive service and pharmaceutical care today ...
Research article Pharmacists cognitive service and pharmaceutical care today ...M. Luisetto Pharm.D.Spec. Pharmacology
 
Problems and challenges faced in consumer reporting of adverse drug reactions...
Problems and challenges faced in consumer reporting of adverse drug reactions...Problems and challenges faced in consumer reporting of adverse drug reactions...
Problems and challenges faced in consumer reporting of adverse drug reactions...Mohammed Alshakka
 

Similar to Running head JUBLIA1JUBLIA2JubliaChambe.docx (20)

anido2017.pdf
anido2017.pdfanido2017.pdf
anido2017.pdf
 
Rational drug rx and writing dentistry for print
Rational drug rx and writing dentistry for printRational drug rx and writing dentistry for print
Rational drug rx and writing dentistry for print
 
Outlining pharmacovigilance
Outlining pharmacovigilanceOutlining pharmacovigilance
Outlining pharmacovigilance
 
Multiple health problems in elderly peoplepage 950Ex.docx
Multiple health problems in elderly peoplepage 950Ex.docxMultiple health problems in elderly peoplepage 950Ex.docx
Multiple health problems in elderly peoplepage 950Ex.docx
 
Evaluation of cutaneous adverse drug reactions due to antimicrobial agents: A...
Evaluation of cutaneous adverse drug reactions due to antimicrobial agents: A...Evaluation of cutaneous adverse drug reactions due to antimicrobial agents: A...
Evaluation of cutaneous adverse drug reactions due to antimicrobial agents: A...
 
New antifungals and TB research
New antifungals and TB researchNew antifungals and TB research
New antifungals and TB research
 
Awareness and attitudes of healthcare professionals in baguio benguet towards...
Awareness and attitudes of healthcare professionals in baguio benguet towards...Awareness and attitudes of healthcare professionals in baguio benguet towards...
Awareness and attitudes of healthcare professionals in baguio benguet towards...
 
Antimicrobial-stewardship.ppt
Antimicrobial-stewardship.pptAntimicrobial-stewardship.ppt
Antimicrobial-stewardship.ppt
 
Local_Drug_Delivery_in_Periodontics.pdf
Local_Drug_Delivery_in_Periodontics.pdfLocal_Drug_Delivery_in_Periodontics.pdf
Local_Drug_Delivery_in_Periodontics.pdf
 
THESIS ENGLISH PRESENTATION
THESIS ENGLISH PRESENTATIONTHESIS ENGLISH PRESENTATION
THESIS ENGLISH PRESENTATION
 
Design for patient safety (NHS Guideline )
Design for patient safety (NHS Guideline )Design for patient safety (NHS Guideline )
Design for patient safety (NHS Guideline )
 
BIOTECHNOLOGY AND ITS APPLICATION TO VETERINARY SCIENCE
BIOTECHNOLOGY AND ITS APPLICATION TO VETERINARY SCIENCEBIOTECHNOLOGY AND ITS APPLICATION TO VETERINARY SCIENCE
BIOTECHNOLOGY AND ITS APPLICATION TO VETERINARY SCIENCE
 
Detection of Drug Interactions via Android Smartphone: Design and Implementat...
Detection of Drug Interactions via Android Smartphone: Design and Implementat...Detection of Drug Interactions via Android Smartphone: Design and Implementat...
Detection of Drug Interactions via Android Smartphone: Design and Implementat...
 
Haapalinna the new modalities ecosystem project what is there for me
Haapalinna the new modalities ecosystem project what is there for meHaapalinna the new modalities ecosystem project what is there for me
Haapalinna the new modalities ecosystem project what is there for me
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
Short courses in food safety risk assessment
Short courses in food safety risk assessmentShort courses in food safety risk assessment
Short courses in food safety risk assessment
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
Ofloxacin induced multiple fixed drug eruptions – A case report
Ofloxacin induced multiple fixed drug eruptions – A case reportOfloxacin induced multiple fixed drug eruptions – A case report
Ofloxacin induced multiple fixed drug eruptions – A case report
 
Research article Pharmacists cognitive service and pharmaceutical care today ...
Research article Pharmacists cognitive service and pharmaceutical care today ...Research article Pharmacists cognitive service and pharmaceutical care today ...
Research article Pharmacists cognitive service and pharmaceutical care today ...
 
Problems and challenges faced in consumer reporting of adverse drug reactions...
Problems and challenges faced in consumer reporting of adverse drug reactions...Problems and challenges faced in consumer reporting of adverse drug reactions...
Problems and challenges faced in consumer reporting of adverse drug reactions...
 

More from wlynn1

Running head MARKETING ANALYSIS ASSIGNMENTS .docx
Running head MARKETING ANALYSIS ASSIGNMENTS                      .docxRunning head MARKETING ANALYSIS ASSIGNMENTS                      .docx
Running head MARKETING ANALYSIS ASSIGNMENTS .docxwlynn1
 
Running head MANAGING A DIVERSE WORKFORCE1MANAGING A DIVERSE.docx
Running head MANAGING A DIVERSE WORKFORCE1MANAGING A DIVERSE.docxRunning head MANAGING A DIVERSE WORKFORCE1MANAGING A DIVERSE.docx
Running head MANAGING A DIVERSE WORKFORCE1MANAGING A DIVERSE.docxwlynn1
 
Running head MANAGING TECHNOLOGICAL INNOVATION IN DIGITAL BUS.docx
Running head MANAGING TECHNOLOGICAL INNOVATION IN DIGITAL BUS.docxRunning head MANAGING TECHNOLOGICAL INNOVATION IN DIGITAL BUS.docx
Running head MANAGING TECHNOLOGICAL INNOVATION IN DIGITAL BUS.docxwlynn1
 
Running head MANAGERIAL REPORT FOR SUPERVISING MANAGER 1MAN.docx
Running head MANAGERIAL REPORT FOR SUPERVISING MANAGER 1MAN.docxRunning head MANAGERIAL REPORT FOR SUPERVISING MANAGER 1MAN.docx
Running head MANAGERIAL REPORT FOR SUPERVISING MANAGER 1MAN.docxwlynn1
 
Running head MANAGING DYNAMIC ENVIRONMENTS FINAL .docx
Running head MANAGING DYNAMIC ENVIRONMENTS FINAL         .docxRunning head MANAGING DYNAMIC ENVIRONMENTS FINAL         .docx
Running head MANAGING DYNAMIC ENVIRONMENTS FINAL .docxwlynn1
 
Running head MANAGING DONUT FRANCHISES1MANAGING DONUT FRANCHIS.docx
Running head MANAGING DONUT FRANCHISES1MANAGING DONUT FRANCHIS.docxRunning head MANAGING DONUT FRANCHISES1MANAGING DONUT FRANCHIS.docx
Running head MANAGING DONUT FRANCHISES1MANAGING DONUT FRANCHIS.docxwlynn1
 
Running head MANAGEMENT DILEMMAS1MANAGEMENT DILEMMAS6.docx
Running head MANAGEMENT DILEMMAS1MANAGEMENT DILEMMAS6.docxRunning head MANAGEMENT DILEMMAS1MANAGEMENT DILEMMAS6.docx
Running head MANAGEMENT DILEMMAS1MANAGEMENT DILEMMAS6.docxwlynn1
 
Running head MANAGERIAL ACCOUNTING 1MANAGERIAL ACCOUNTING.docx
Running head MANAGERIAL ACCOUNTING 1MANAGERIAL ACCOUNTING.docxRunning head MANAGERIAL ACCOUNTING 1MANAGERIAL ACCOUNTING.docx
Running head MANAGERIAL ACCOUNTING 1MANAGERIAL ACCOUNTING.docxwlynn1
 
Running head LOGISTIC REGRESSION .docx
Running head LOGISTIC REGRESSION                                 .docxRunning head LOGISTIC REGRESSION                                 .docx
Running head LOGISTIC REGRESSION .docxwlynn1
 
Running head MANAGEMENT OF CONGESTIVE HEART FAILURE THROUGH MO .docx
Running head MANAGEMENT OF CONGESTIVE HEART FAILURE THROUGH MO  .docxRunning head MANAGEMENT OF CONGESTIVE HEART FAILURE THROUGH MO  .docx
Running head MANAGEMENT OF CONGESTIVE HEART FAILURE THROUGH MO .docxwlynn1
 
Running head MALWARE .docx
Running head MALWARE                                             .docxRunning head MALWARE                                             .docx
Running head MALWARE .docxwlynn1
 
Running head LOS ANGELES AND NEW YORK BUDGETARY COMPARISON .docx
Running head LOS ANGELES AND NEW YORK BUDGETARY COMPARISON     .docxRunning head LOS ANGELES AND NEW YORK BUDGETARY COMPARISON     .docx
Running head LOS ANGELES AND NEW YORK BUDGETARY COMPARISON .docxwlynn1
 
Running head MAJOR PROJECT1MAJOR PROJECT9Initial Ou.docx
Running head MAJOR PROJECT1MAJOR PROJECT9Initial Ou.docxRunning head MAJOR PROJECT1MAJOR PROJECT9Initial Ou.docx
Running head MAJOR PROJECT1MAJOR PROJECT9Initial Ou.docxwlynn1
 
Running Head MAJOR CONCERNS OF CLIMATE CHANGE IN CHINA 1MAJO.docx
Running Head MAJOR CONCERNS OF CLIMATE CHANGE IN CHINA 1MAJO.docxRunning Head MAJOR CONCERNS OF CLIMATE CHANGE IN CHINA 1MAJO.docx
Running Head MAJOR CONCERNS OF CLIMATE CHANGE IN CHINA 1MAJO.docxwlynn1
 
Running Head LOGISTICS1Running Head LOGISTICS7.docx
Running Head LOGISTICS1Running Head LOGISTICS7.docxRunning Head LOGISTICS1Running Head LOGISTICS7.docx
Running Head LOGISTICS1Running Head LOGISTICS7.docxwlynn1
 
Running head LOGIC MODELLOGIC MODEL 2Logic modelStu.docx
Running head LOGIC MODELLOGIC MODEL 2Logic modelStu.docxRunning head LOGIC MODELLOGIC MODEL 2Logic modelStu.docx
Running head LOGIC MODELLOGIC MODEL 2Logic modelStu.docxwlynn1
 
Running head LITERATURE REVIEW1MINORITY BOYS SCHOOL DROPOUT A.docx
Running head LITERATURE REVIEW1MINORITY BOYS SCHOOL DROPOUT A.docxRunning head LITERATURE REVIEW1MINORITY BOYS SCHOOL DROPOUT A.docx
Running head LITERATURE REVIEW1MINORITY BOYS SCHOOL DROPOUT A.docxwlynn1
 
Running head LIVING WITH CHRONIC ILLNESS1Living with Chroni.docx
Running head LIVING WITH CHRONIC ILLNESS1Living with Chroni.docxRunning head LIVING WITH CHRONIC ILLNESS1Living with Chroni.docx
Running head LIVING WITH CHRONIC ILLNESS1Living with Chroni.docxwlynn1
 
Running Head LITERATURE REVIEW2LITERATURE REVIEW 2.docx
Running Head LITERATURE REVIEW2LITERATURE REVIEW 2.docxRunning Head LITERATURE REVIEW2LITERATURE REVIEW 2.docx
Running Head LITERATURE REVIEW2LITERATURE REVIEW 2.docxwlynn1
 
Running head LOGIC MODELLOGIC MODEL 4Situ.docx
Running head LOGIC MODELLOGIC MODEL 4Situ.docxRunning head LOGIC MODELLOGIC MODEL 4Situ.docx
Running head LOGIC MODELLOGIC MODEL 4Situ.docxwlynn1
 

More from wlynn1 (20)

Running head MARKETING ANALYSIS ASSIGNMENTS .docx
Running head MARKETING ANALYSIS ASSIGNMENTS                      .docxRunning head MARKETING ANALYSIS ASSIGNMENTS                      .docx
Running head MARKETING ANALYSIS ASSIGNMENTS .docx
 
Running head MANAGING A DIVERSE WORKFORCE1MANAGING A DIVERSE.docx
Running head MANAGING A DIVERSE WORKFORCE1MANAGING A DIVERSE.docxRunning head MANAGING A DIVERSE WORKFORCE1MANAGING A DIVERSE.docx
Running head MANAGING A DIVERSE WORKFORCE1MANAGING A DIVERSE.docx
 
Running head MANAGING TECHNOLOGICAL INNOVATION IN DIGITAL BUS.docx
Running head MANAGING TECHNOLOGICAL INNOVATION IN DIGITAL BUS.docxRunning head MANAGING TECHNOLOGICAL INNOVATION IN DIGITAL BUS.docx
Running head MANAGING TECHNOLOGICAL INNOVATION IN DIGITAL BUS.docx
 
Running head MANAGERIAL REPORT FOR SUPERVISING MANAGER 1MAN.docx
Running head MANAGERIAL REPORT FOR SUPERVISING MANAGER 1MAN.docxRunning head MANAGERIAL REPORT FOR SUPERVISING MANAGER 1MAN.docx
Running head MANAGERIAL REPORT FOR SUPERVISING MANAGER 1MAN.docx
 
Running head MANAGING DYNAMIC ENVIRONMENTS FINAL .docx
Running head MANAGING DYNAMIC ENVIRONMENTS FINAL         .docxRunning head MANAGING DYNAMIC ENVIRONMENTS FINAL         .docx
Running head MANAGING DYNAMIC ENVIRONMENTS FINAL .docx
 
Running head MANAGING DONUT FRANCHISES1MANAGING DONUT FRANCHIS.docx
Running head MANAGING DONUT FRANCHISES1MANAGING DONUT FRANCHIS.docxRunning head MANAGING DONUT FRANCHISES1MANAGING DONUT FRANCHIS.docx
Running head MANAGING DONUT FRANCHISES1MANAGING DONUT FRANCHIS.docx
 
Running head MANAGEMENT DILEMMAS1MANAGEMENT DILEMMAS6.docx
Running head MANAGEMENT DILEMMAS1MANAGEMENT DILEMMAS6.docxRunning head MANAGEMENT DILEMMAS1MANAGEMENT DILEMMAS6.docx
Running head MANAGEMENT DILEMMAS1MANAGEMENT DILEMMAS6.docx
 
Running head MANAGERIAL ACCOUNTING 1MANAGERIAL ACCOUNTING.docx
Running head MANAGERIAL ACCOUNTING 1MANAGERIAL ACCOUNTING.docxRunning head MANAGERIAL ACCOUNTING 1MANAGERIAL ACCOUNTING.docx
Running head MANAGERIAL ACCOUNTING 1MANAGERIAL ACCOUNTING.docx
 
Running head LOGISTIC REGRESSION .docx
Running head LOGISTIC REGRESSION                                 .docxRunning head LOGISTIC REGRESSION                                 .docx
Running head LOGISTIC REGRESSION .docx
 
Running head MANAGEMENT OF CONGESTIVE HEART FAILURE THROUGH MO .docx
Running head MANAGEMENT OF CONGESTIVE HEART FAILURE THROUGH MO  .docxRunning head MANAGEMENT OF CONGESTIVE HEART FAILURE THROUGH MO  .docx
Running head MANAGEMENT OF CONGESTIVE HEART FAILURE THROUGH MO .docx
 
Running head MALWARE .docx
Running head MALWARE                                             .docxRunning head MALWARE                                             .docx
Running head MALWARE .docx
 
Running head LOS ANGELES AND NEW YORK BUDGETARY COMPARISON .docx
Running head LOS ANGELES AND NEW YORK BUDGETARY COMPARISON     .docxRunning head LOS ANGELES AND NEW YORK BUDGETARY COMPARISON     .docx
Running head LOS ANGELES AND NEW YORK BUDGETARY COMPARISON .docx
 
Running head MAJOR PROJECT1MAJOR PROJECT9Initial Ou.docx
Running head MAJOR PROJECT1MAJOR PROJECT9Initial Ou.docxRunning head MAJOR PROJECT1MAJOR PROJECT9Initial Ou.docx
Running head MAJOR PROJECT1MAJOR PROJECT9Initial Ou.docx
 
Running Head MAJOR CONCERNS OF CLIMATE CHANGE IN CHINA 1MAJO.docx
Running Head MAJOR CONCERNS OF CLIMATE CHANGE IN CHINA 1MAJO.docxRunning Head MAJOR CONCERNS OF CLIMATE CHANGE IN CHINA 1MAJO.docx
Running Head MAJOR CONCERNS OF CLIMATE CHANGE IN CHINA 1MAJO.docx
 
Running Head LOGISTICS1Running Head LOGISTICS7.docx
Running Head LOGISTICS1Running Head LOGISTICS7.docxRunning Head LOGISTICS1Running Head LOGISTICS7.docx
Running Head LOGISTICS1Running Head LOGISTICS7.docx
 
Running head LOGIC MODELLOGIC MODEL 2Logic modelStu.docx
Running head LOGIC MODELLOGIC MODEL 2Logic modelStu.docxRunning head LOGIC MODELLOGIC MODEL 2Logic modelStu.docx
Running head LOGIC MODELLOGIC MODEL 2Logic modelStu.docx
 
Running head LITERATURE REVIEW1MINORITY BOYS SCHOOL DROPOUT A.docx
Running head LITERATURE REVIEW1MINORITY BOYS SCHOOL DROPOUT A.docxRunning head LITERATURE REVIEW1MINORITY BOYS SCHOOL DROPOUT A.docx
Running head LITERATURE REVIEW1MINORITY BOYS SCHOOL DROPOUT A.docx
 
Running head LIVING WITH CHRONIC ILLNESS1Living with Chroni.docx
Running head LIVING WITH CHRONIC ILLNESS1Living with Chroni.docxRunning head LIVING WITH CHRONIC ILLNESS1Living with Chroni.docx
Running head LIVING WITH CHRONIC ILLNESS1Living with Chroni.docx
 
Running Head LITERATURE REVIEW2LITERATURE REVIEW 2.docx
Running Head LITERATURE REVIEW2LITERATURE REVIEW 2.docxRunning Head LITERATURE REVIEW2LITERATURE REVIEW 2.docx
Running Head LITERATURE REVIEW2LITERATURE REVIEW 2.docx
 
Running head LOGIC MODELLOGIC MODEL 4Situ.docx
Running head LOGIC MODELLOGIC MODEL 4Situ.docxRunning head LOGIC MODELLOGIC MODEL 4Situ.docx
Running head LOGIC MODELLOGIC MODEL 4Situ.docx
 

Recently uploaded

Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfSumit Tiwari
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformChameera Dedduwage
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTiammrhaywood
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxthorishapillay1
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentInMediaRes1
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Celine George
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxmanuelaromero2013
 
Class 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdfClass 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdfakmcokerachita
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon AUnboundStockton
 
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting DataJhengPantaleon
 
ENGLISH5 QUARTER4 MODULE1 WEEK1-3 How Visual and Multimedia Elements.pptx
ENGLISH5 QUARTER4 MODULE1 WEEK1-3 How Visual and Multimedia Elements.pptxENGLISH5 QUARTER4 MODULE1 WEEK1-3 How Visual and Multimedia Elements.pptx
ENGLISH5 QUARTER4 MODULE1 WEEK1-3 How Visual and Multimedia Elements.pptxAnaBeatriceAblay2
 

Recently uploaded (20)

Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy Reform
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptx
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media Component
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptx
 
Class 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdfClass 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdf
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
9953330565 Low Rate Call Girls In Rohini Delhi NCR
9953330565 Low Rate Call Girls In Rohini  Delhi NCR9953330565 Low Rate Call Girls In Rohini  Delhi NCR
9953330565 Low Rate Call Girls In Rohini Delhi NCR
 
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon A
 
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
 
ENGLISH5 QUARTER4 MODULE1 WEEK1-3 How Visual and Multimedia Elements.pptx
ENGLISH5 QUARTER4 MODULE1 WEEK1-3 How Visual and Multimedia Elements.pptxENGLISH5 QUARTER4 MODULE1 WEEK1-3 How Visual and Multimedia Elements.pptx
ENGLISH5 QUARTER4 MODULE1 WEEK1-3 How Visual and Multimedia Elements.pptx
 

Running head JUBLIA1JUBLIA2JubliaChambe.docx

  • 1. Running head: JUBLIA 1 JUBLIA 2 Jublia Chamberlain College of Nursing NR-293, Pharmacology Linda Le Professor Ward February 14, 2019 Jublia This brochure has been designed to inform the people about the use of Efinaconazole for the treatment of onychomycosis. Onychomycosis is known as a fungal infection of the nail. This is targeted to educate the people on the treatment and use of Jublia as a toenail treatment. The brochure explains a small intro of necessary information regarding medicine like drug class, mechanism of action, and treat guide. The side effects and interactions are also explained. This is designed to provide awareness to layman regarding toenail infections.
  • 2. References Elewski, B. E., Rich, P., Pollak, R., Pariser, D. M., Watanabe, S., Senda, H., ... & Oli n, J. T. (2013). Efinaconazole 10% solution in the treatment of toenail onychomycosis: two phase III multicenter, randomized, double-blind studies. Journal of the American Academy of Dermatology, 68(4), 600-608. Tschen, E. H., Bucko, A. D., Oizumi, N., Kawabata, H., Olin, J. T., & Pillai, R. (2013). Efinaconazole solution in the treatment of toenail onychomycosis: a phase 2, multicenter, randomized, double-blind study. J Drugs Dermatol, 12(2), 186- 92. RentSilverSpring.xlsx DATASize (Square feet) Rent ($)52411106161175666119083014104501210550122578014808 15149010701495610168083518106601625590146967513957441 15082011409121220628143464515198401105800113080412509 50144980011687871224960139175011456901093840135385015 30965165010601740665123577515509601545827158365515755
  • 3. 35131062511957491200634118564114448601385740127559310 50880165089513406921560 Starbucks.xlsx DATATearViscosityPressurePlate Gap0.00350.00180.000.000.00350.00170.000.000.45319.00186. 001.800.85380.00174.001.800.35350.00180.000.000.30300.001 80.000.000.70400.00180.000.001.90350.00190.000.000.25350.0 0180.000.000.10319.00186.00-1.800.15380.00186.00- 1.803.90350.00180.003.000.00380.00174.00- 1.800.55350.00180.000.000.00350.00180.00- 3.000.05319.00174.00- 1.800.40319.00174.001.804.30380.00186.001.800.00350.00180. 000.00 VinhoVerde.xlsx DATAFixed AcidityVolatile AcidityCitric AcidResidual SugarChloridesFree Sulfur DioxideTotal Sulfur DioxideDensitypHSulphatesAlcoholQuality11.50.30.620.067122 70.99813.110.9710.167.70.7150.012.10.06431430.993713.410.5 711.8610.40.5750.612.60.076112413.160.69959.20.630.212.70. 09729650.99883.280.589.657.90.350.463.60.07815370.99733.3 50.8612.888.90.7450.182.50.07715480.997393.20.479.767.60.5 10.242.40.0918380.9983.470.669.6610.80.50.462.50.0735271.0 0013.050.649.556.40.470.42.40.0718190.99633.560.7310.669.9 0.630.242.40.0776330.99743.090.579.456.90.68502.50.1052237 0.99663.460.5710.667.30.450.365.90.07412870.99783.330.8310 .556.80.810.0520.076140.995623.510.6610.867.50.510.021.70.0 8413310.995383.360.5410.5610.40.340.583.70.1746160.9973.1 90.711.367.10.460.142.80.07615370.996243.360.4910.759.10.5 0.31.90.0658170.997743.320.7110.567.30.690.322.20.06935104 0.996323.330.519.557.70.602.60.0557130.996393.380.5610.856 .70.460.241.70.07718340.99483.390.610.668.60.470.272.30.055 14280.995163.180.811.258.30.650.12.90.08917400.998033.290. 559.5560.310.473.60.06718420.995493.390.661168.60.490.281. 90.11201360.99722.931.959.967.90.540.342.50.0768170.99235
  • 4. 3.20.7213.1810.20.490.632.90.07210260.99683.160.7812.5780. 330.532.50.09118800.99763.370.89.667.60.390.312.30.0822371 0.99823.520.659.757.10.5902.10.0919140.994883.420.5511.578 .30.60.132.60.0856240.99843.310.599.268.80.460.452.60.06571 80.99473.320.791468.50.470.271.90.05818380.995183.160.851 1.1610.20.6450.361.80.0535140.99823.170.4210611.60.320.552 .80.08135671.00023.320.9210.876.30.550.151.80.07726350.993 143.320.8211.667.50.380.482.60.07322840.99723.320.79.649.1 0.7650.041.60.0784140.9983.290.549.748.41.0350.1560.073115 40.9993.370.499.956.20.560.091.70.05324320.994023.540.611. 357.30.740.081.70.09410450.995763.240.59.857.80.390.4220.0 869210.995263.390.6611.6610.40.440.421.50.14534480.998323 .380.869.9311.60.470.441.60.14736510.998363.380.869.948.30. 650.12.90.08917400.998033.290.559.556.30.550.151.80.077263 50.993143.320.8211.666.71.040.082.30.06719320.996483.520.5 71147.20.330.331.70.0613130.9963.231.11086.80.81501.20.267 16290.994713.320.519.835.50.490.031.80.04428870.99083.50.8 21487.40.590.084.40.0866290.99743.380.594 13.313.3 A small business analyst seeks to determine which variablesshould be used to predict small-business mean annual revenuefor U.S. metropolitan areas. The analyst decides to considerthe independent variables age, the mean age (in months) of smallbusinesses in the metropolitan area; and BizAnalyzer, the meanBizAnalyzer score of small businesses in the metropolitan area.(The BizAnalyzer score measures on a scale of 1 to100 the levelof risk that the small businesses in the metropolitan area present topotential lenders.) The dependent variable, revenue, is mean annualrevenue. Using data collected from a sample of 25 metropolitanareas, the regression results are:a. State the multiple regression equation.b. Interpret the meaning of the slopes, b1 and b2, in this problem.c. What conclusions can you reach concerning mean annualrevenue? 13.513.5 The production of wine is a multibillion-dollar worldwideindustry. In an attempt to develop a model of wine qualityas judged by wine experts, data was collected from red
  • 5. winevariants of Portuguese “Vinho Verde” wine. A sample of 50wines is stored in VinhoVerde . (Data extracted from P. Cortez,A. Cerdeira, F. Almeida, T. Matos, and J. Reis, “Modeling WineDecision Support Systems, 47, 2009, pp. 547– 553 and bit.ly/9xKlEa.) Develop a multiple linear regression model to predictwine quality, measured on a scale from 0 (very bad) to 10 (excellent)based on alcohol content (%) and the amount of chlorides.a. State the multiple regression equation.b. Interpret the meaning of the slopes, b1 and b2, in this problem.c. E xplain why the regression coefficient, b0, has no practicalmeaning in the context of this problem.d. Predict the mean wine quality rating for wines that have 10%alcohol and chlorides of 0.08.e. Construct a 95% confidence interval estimate for the meanwine quality rating for wines that have 10% alcohol and chloridesof 0.08.f. Construct a 95% prediction interval for the wine quality rating foran individual wine that has 10% alcohol and chlorides of 0.08.g. What conclusions can you reach concerning this regressionmodel? Jublia EFINACONAZOLE (EF-IN-A-KON-A-ZOLE) DRUG CLASS This drug belongs to the class `Azole antifungal` ACTION Inhibits lanosterol 14a-demethylase which involved in synthesis of a constituent of fungal cell membranes. DOSE INFORMATION Once daily for 48 weeks. DRUG INTERACTIONS It may interact with other medicines you take. It is better to inform the doctor about outer medicines you are currently
  • 6. taking. adverse effects Itchiness, blister, and swelling. Allergic reaction in rare cases. ASSESSMENT Inspect the affected area thoroughly as it is slow process. A feeling of itchiness may indicate a need to continue medicine. Patient education The treatment of onychomycosis may take up to 48 weeks. Do not discontinue its usage even if symptoms diminish. Complete the full course as directed by the doctor. Avoid pedicure, nail enamel or any cosmetics on the affected area during therapy. Inform the doctor if the patient is pregnant or a lactating mother. Wait 10 minutes after washing the area to apply the medicine. NURSING MANAGEMENT Apply Jublia on the affected toenail. Make sure the toenail is completely dry and clean prior to the application. Use a flow through brush in the applicator for the application. Make sure the effects area is completely covered with the solution.
  • 7. .MsftOfcThm_Accent3_Fill { fill:#1F1F50; } Medication Teaching Plan Assignment GuidelinesPurpose The purpose of this assignment is for the student to synthesize pharmacological knowledge (i.e., core drug knowledge, core patient variables, and nursing implications) of pharmacotherapeutic agents into a useful teaching and learning tool for nurses and patients. Course Outcomes This assignment enables the student to meet the following course outcomes. · CO1 Apply the concepts of pharmacotherapeutics, pharmacokinetics, pharmacodynamics, and pharmacogenomics to the use of specific medication classifications in specific health conditions and in consideration of medication side/adverse effects, nursing implications, and medication teaching. (POs 1, 2, and 3) · CO2 Apply principles of health promotion, as well as illness and injury prevention, to promote safety and effectiveness of commonly used pharmacologic therapy across the lifespan, taking into consideration sociocultural, genetic/genomic, developmental, and gender implications. (POs 3 and 8) · CO3 Utilize the nursing process in understanding the effects of drug therapy on health outcomes across the lifespan within the framework of a diverse population of individuals, families, and communities. (PO 4) Due Date
  • 8. Refer to Course Calendar for details. The Late Assignment Policy applies to this assignment. Total Points Possible 100 PointsRequirements 1. Choose a pharmacological agent that has been on the market less than 5 years. 2. Research the literature and obtain two to three resources for current, evidence-based information related to the pharmacological agent. You must submit your resources with the assignment. Identify the following key/relevant drug information that will be used to develop a medication teaching brochure: · Drug Class · Mechanism of Action · Drug Administration and Dosage · Drug/food Interactions · Lab effects/Interference 3. Design a brochure to be used as a patient teaching tool containing the identified relevant/key information outlined above and the following important information: · Nursing Management · Patient Education Considerations · Patient Assessment · Potential Side Effects/Adverse Effects/Toxicities · Special considerations Preparing the Assignment 1. After selecting your pharmacotherapeutic agent, use the Chamberlain online library or other database to research the key/relevant drug information. 2. Create your teaching brochure using MS Word or PowerPoint. Microsoft Word has built-in and online templates for brochures. You may choose one of these for your format. The brochure should be printed on one page, two-sided. 3. Include appropriate images, graphics, bulleted items, and subtitles in your brochure. Choose images that illustrate your
  • 9. points and do not serve as mere decorations. 4. Use no higher than seventh-grade reading level, except for required medical terminology. Microsoft Word will calculate a Flesch Kincaid Grade Level for you. Go to Review > Spelling and Grammar. When the check is complete, Word will give you the statistics. You may need to save your file with a new name and temporarily delete required medical terms and then run the Flesch Kincaid statistics again to get to the seventh-grade reading level. 5. Complete a separate document that contains the following information: · Your name, date and class · A short paragraph describing the intended audience and use for your teaching brochure. For example, is this for teaching a pediatric patient who is newly diagnosed with asthma about the new drug? Is it designed to teach an older adult about a new cholesterol drug? · A reference page in APA format The brochure is not a paper that follows APA format so please use your creativity when developing the brochure. Consider your audience when choosing font, style and graphics. 6. Submit the brochure and the one-page document to the assignment by the due date. Directions and Assignment Criteria Category Points % Description Brochure: Key/Relevant Drug Information 30 30% Brochure contains following key/relevant drug information
  • 10. · Drug Class · Mechanism of Action · Drug Administration and Dosage · Drug Interactions · Lab effects/interference · Special Considerations · Potential Side Effects/Adverse Effects/Toxicities Brochure: Patient Education Considerations 35 35% Brochure contains the following patient education information · Nursing Management · Patient Education Considerations · Patient Assessment · Potential Side Effects/Adverse Effects/Toxicities · Special considerations Brochure: Visual Effects/Creativity 10 10% Brochure meets all of the following · Developed per the required standard · Appropriate for the intended audience · Flesch Kincaid reading level is not higher than seventh grade · Graphics do not distract from the purpose of the brochure · Visually appealing One Page Paper 15 15%
  • 11. One page paper is clearly written and contains the following information: · Name · Date · Class · A short paragraph describing the intended audience and use for the teaching brochure. · A reference page APA format 5 5% Reference page is present and follows APA format. At least two sources are used and submitted with work Writing Mechanics 5 5% Writing follows rules of grammar, spelling, word usage, punctuation, and other aspects of formal written work as found in the 6th edition of the APA manual Total 100 100% NR293Pharmacology for Nursing Practice NR293 Medication Teaching Plan Assignment Guidelines.docx Revised 03/13/2018 WS/SCM 1
  • 12. Grading Rubric Category Brochure: Key/Relevant Drug Information 30 Points 25 Points 20 Points 15 points 0 Points Presentation of information on brochure is accurate and includes all of the following elements: · Drug Class · Mechanism of Action · Drug Administration and Dosage · Drug Interactions · Lab effects/interference · Special Considerations · Potential Side Effects/Adverse Effects/Toxicities Presentation of informationon brochure is accurate and includes six(6) of the following elements: · Drug Class · Mechanism of Action · Drug Administration and Dosage · Drug Interactions · Lab effects/interference · Special Considerations · Potential Side Effects/Adverse Effects/Toxicities Presentation of information on brochureis accurate andincludes five (5) of the following elements: · Drug Class · Mechanism of Action · Drug Administration and Dosage · Drug Interactions · Lab effects/interference
  • 13. · Special Considerations · Potential Side Effects/Adverse Effects/Toxicities Presentation of informationon brochure is accurate and includes four (4) of the following elements: · Drug Class · Mechanism of Action · Drug Administration and Dosage · Drug Interactions · Lab effects/interference · Special Considerations · Potential Side Effects/Adverse Effects/Toxicities Presentation of informationon brochure includes less than four (4) of the following elements: · Drug Class · Mechanism of Action · Drug Administration and Dosage · Drug Interactions · Lab effects/interference · Special Considerations · Potential Side Effects/Adverse Effects/Toxicities Brochure: Patient Education Considerations 35 points 25 Points 15 Points 10 Points 0 Points Presentation of informationon brochure is accurate and includes all of the following elements: · Nursing Management · Patient Education Considerations · Patient Assessment · Potential Side Effects/Adverse Effects/Toxicities · Special considerations
  • 14. Presentation of informationon brochure is accurate and includes four(4) of the following elements: · Nursing Management · Patient Education Considerations · Patient Assessment · Potential Side Effects/Adverse Effects/Toxicities · Special considerations Presentation of informationon brochure is accurate and includes three (3) of the following elements: · Nursing Management · Patient Education Considerations · Patient Assessment · Potential Side Effects/Adverse Effects/Toxicities · Special considerations Presentation of informationon brochure is accurate and includes two (2) of the following elements: · Nursing Management · Patient Education Considerations · Patient Assessment · Potential Side Effects/Adverse Effects/Toxicities · Special considerations Presentation of informationon brochure includes less than two (2) of the following elements: · Nursing Management · Patient Education Considerations · Patient Assessment · Potential Side Effects/Adverse Effects/Toxicities · Special Considerations · Brochure: Visual Effects/Creativity 10 Points 8 Points 6 Points 4 Points 0 Points
  • 15. Presentation of informationon brochureincludes all of the following elements: · Developed per the required standard · Appropriate for the intended audience · Flesch Kincaid reading level is not higher than seventh grade · Graphics do not distract from the purpose of the brochure · Visually appealing Presentation of informationon brochure includes four (4) of the following elements: · Developed per the required standard · Appropriate for the intended audience · Flesch Kincaid reading level is not higher than seventh grade · Graphics do not distract from the purpose of the brochure · Visually appealing Presentation of informationon brochure includes three (3) of the following elements: · Developed per the required standard · Appropriate for the intended audience · Flesch Kincaid reading level is not higher than seventh grade · Graphics do not distract from the purpose of the brochure · Visually appealing Presentation of informationon brochure includes two (2) of the following elements: · Developed per the required standard · Appropriate for the intended audience · Flesch Kincaid reading level is not higher than seventh grade · Graphics do not distract from the purpose of the brochure · Visually appealing Presentation of information on brochureincludes less than two(2) of the following elements: · Developed per the required standard · Appropriate for the intended audience
  • 16. · Flesch Kincaid reading level is not higher than seventh grade · Graphics do not distract from the purpose of the brochure · Visually appealing One page paper 15 Points 12 Points 9 Points 6 Points 0 Points Presentation of information in the paperis clearly written andincludes all of the following elements: · Name · Date · Class · A short paragraph describing the intended audience and use for the teaching brochure. · A reference page Presentation of informationin the paper is clearly written and includes four (4) of the following elements: · Name · Date · Class · A short paragraph describing the intended audience and use for the teaching brochure. · A reference page Presentation of informationin the paper is clearly written and includes three (3) of the following elements: · Name · Date · Class · A short paragraph describing the intended audience and use for the teaching brochure. · A reference page Presentation of informationin the paper is clearly written andincludes two (2) of the following elements:
  • 17. · Name · Date · Class · A short paragraph describing the intended audience and use for the teaching brochure. · A reference page Presentation of informationin the paperincludes less than two (2) of the following elements: · Name · Date · Class · A short paragraph describing the intended audience and use for the teaching brochure. · A reference page APA Format 5 Points 4 Points 0 Point APA guidelines, as per the 6th edition of the manual, are demonstrated for all the following: · Reference page is present and follows APA format · At least two sources are used and submitted with work APA guidelines, as per the 6th edition of the manual, are demonstrated for one (1) of the following: · Reference page is present and follows APA format · At least two sources are used and submitted with work APA guidelines, as per the 6th edition of the manual, are demonstrated for none of the following:
  • 18. · Reference page is present and follows APA format · At least two sources are used and submitted with work Writing Mechanics 5 Points 4 Points 3 Points 1 Point 0 Point 0–2 errors or exceptions to the rules of grammar, spelling, word usage, punctuation, and other aspects of formal written work as found in the 6th edition of the APA manual 3–4 errors or exceptions to the rules of grammar, spelling, word usage, punctuation, and other aspects of formal written work as found in the 6th edition of the APA manual 5–6 errors or exceptions to the rules of grammar, spelling, word usage, punctuation, and other aspects of formal written work as found in the 6th edition of the APA manual 7–8 errors or exceptions to the rules of grammar, spelling, word usage, punctuation, and other aspects of formal written work as found in the 6th edition of the APA manual 9 or greater errors or exceptions to the rules of grammar, spelling, word usage, punctuation, and other aspects of formal written work as found in the 6th edition of the APA manual Total Points Possible = 100 points Student’s Score ______/100 Points Comments:
  • 19. NR293 Medication Teaching Plan Assignment Guidelines.docx Revised 03/13/2018 WS/SCM 7